Skip to main content
. 2017 Aug 4;1(1):e000039. doi: 10.1136/bmjpo-2017-000039

Figure 1.

Figure 1

Percentage age distribution of lamotrigine-treated population who experienced Stevens-Johnson syndrome/toxic epidermal necrolysis (cases), patients receiving lamotrigine who experienced non-cutaneous adverse drug reactions (reference A) and experienced Stevens-Johnson syndrome/toxic epidermal necrolysis after other drugs (reference B). Many of the reports for ages <1 year old concern in utero exposure and congenital anomalies.